Pahlka's "Cascade of Rigidity" concept warns that seemingly reasonable safety rules for new technologies like AI can become insurmountable barriers within an overburdened, risk-averse bureaucracy, preventing adoption altogether rather than ensuring safe use.

Drug developers often operate under a hyper-conservative perception of FDA requirements, avoiding novel approaches even when regulators might encourage them. This anticipatory compliance, driven by risk aversion, becomes a greater constraint than the regulations themselves, slowing down innovation and increasing costs.

A regulator who approves a new technology that fails faces immense public backlash and career ruin. Conversely, they receive little glory for a success. This asymmetric risk profile creates a powerful incentive to deny or delay new innovations, preserving the status quo regardless of potential benefits.

Regulating technology based on anticipating *potential* future harms, rather than known ones, is a dangerous path. This 'precautionary principle,' common in Europe, stifles breakthrough innovation. If applied historically, it would have blocked transformative technologies like the automobile or even nuclear power, which has a better safety record than oil.

Calls to regulate AI based on speculative futures like Artificial General Intelligence (AGI) are a flawed basis for policy. These predictions have a poor track record and are often self-serving arguments used by incumbents to justify regulations that entrench their market position today.

Policymakers confront an 'evidence dilemma': act early on potential AI harms with incomplete data, risking ineffective policy, or wait for conclusive evidence, leaving society vulnerable. This tension highlights the difficulty of governing rapidly advancing technology where impacts lag behind capabilities.

Large organizations' natural 'risk-first' mindset leads them to try and reduce all potential AI-related errors to zero before implementation. Hoffman argues this is an impossible task that prevents progress, comparing it to refusing to drive a car until every conceivable road risk is eliminated.

Other scientific fields operate under a "precautionary principle," avoiding experiments with even a small chance of catastrophic outcomes (e.g., creating dangerous new lifeforms). The AI industry, however, proceeds with what Bengio calls "crazy risks," ignoring this fundamental safety doctrine.

The history of nuclear power, where regulation transformed an exponential growth curve into a flat S-curve, serves as a powerful warning for AI. This suggests that AI's biggest long-term hurdle may not be technical limits but regulatory intervention that stifles its potential for a "fast takeoff," effectively regulating it out of rapid adoption.